Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
Position Description The laboratory of Dr. Adrian Krainer at Cold Spring Harbor Laboratory is seeking a highly motivated Postdoctoral Fellow to join an innovative research program and advance a
-
a larger interdisciplinary team of computational and experimental scientists. Our approach uses single-cell omics approaches coupled with high-resolution microscopy and in vitro models to study the
-
, collaborative scientific community at Cold Spring Harbor Laboratory and work closely with investigators and institutional core facilities, including the Single Cell Biology Core, to develop and implement emerging
-
candidate will work on developing and applying advanced single-cell multiomic sequencing technologies1,2 to human cancer samples, primarily in the areas of cancer genomics and transcriptomics, to study tumor
-
Responsibilities The successful candidate will join an interdisciplinary team of computational and experimental scientists to study T cell development and auto-immunity. The lab technician will assist members in
-
interactive streaming and web services. Computer HW/SW support, including desktops (Mac + PC), laptops, printers, and mobile devices. Assist in the training of staff as to maximize their computer and
-
for hematologic malignancies. The ultimate goal is to understand how environmental signals such as diets and nervous system activities modulate blood cell development and cancers. Based on these basic mechanistic
-
working in a lab after completion of their degree (level II requirement) Skills/Experience: The ideal candidate should have experience in mammalian cell culture, molecular cloning methods, PCR, qPCR
-
and the microbiome affect tissue fitness or cancer outcomes. We utilize state-of-the-art experimental and computational approaches to integrate genetic, epigenetic, metabolism and microbiome data
-
Degradation (TPD) therapeutic strategies to abrogate or rewire cancer cell signaling. We have recently established a new discovery platform to expand the landscape of TPD E3 ligases and targeting modalities